MoneyWorks4Me

Nectar Lifesciences - Quaterly Results

14 Feb 2022 Evaluate
The company witnessed a 17.20% growth in the revenue at Rs. 4430.01 millions for the quarter ended December 2021 as compared to Rs. 3779.82 millions during the year-ago period.The Total Profit for the quarter ended December 2021 of Rs. 97.32 millions grew from Rs.-80.56 millionsOperating profit for the quarter ended December 2021 rose to 471.19 millions as compared to 334.28 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 4430.01 3779.82 17.20 11920.23 11941.43 -0.18 15428.96 23631.57 -34.71
Other Income 5.30 6.55 -19.08 107.73 17.03 532.59 27.22 40.06 -32.05
PBIDT 471.19 334.28 40.96 1204.61 826.88 45.68 1129.49 2223.33 -49.20
Interest 176.24 306.34 -42.47 613.78 863.87 -28.95 1120.32 1258.23 -10.96
PBDT 294.95 27.94 955.65 590.83 -36.99 -1697.27 -243.98 965.10 -125.28
Depreciation 142.78 151.01 -5.45 427.10 452.45 -5.60 602.53 607.66 -0.84
PBT 152.17 -123.07 -223.65 163.73 -489.44 -133.45 -846.51 357.44 -336.83
TAX 54.85 -42.51 -229.03 27.10 -167.56 -116.17 -115.04 56.83 -302.43
Deferred Tax 54.85 -42.51 -229.03 27.10 -167.56 -116.17 -200.90 40.21 -599.63
PAT 97.32 -80.56 -220.80 136.63 -321.88 -142.45 -731.47 300.61 -343.33
Equity 224.26 224.26 0.00 224.26 224.26 0.00 224.26 224.26 0.00
PBIDTM(%) 9.18 7.72 19.04 10.11 6.92 45.94 6.41 8.42 -23.95
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..